TP53 and cancer: We found that BI-2536, GW843682X, Epothilone B, Afatinib and Gefitinib have significantly lower IC50 values in TP53-mutated cancer cell lines than in TP53-wildtype cancer cell lines (P-value < 0.05, FDR < 0.2, Supplementary Table S21).